INSERM U1149, Université de Paris, Centre de Recherche sur l'inflammation, Team Gut Inflammation, Paris, France.
Laboratory of Excellence Labex INFLAMEX, Sorbonne Paris-Cité, Paris, France.
Inflamm Bowel Dis. 2021 Oct 18;27(10):1653-1660. doi: 10.1093/ibd/izab030.
Ileal pouch-anal anastomosis (IPAA) is the standard of care after total proctocolectomy for ulcerative colitis (UC). However, inflammation often develops in the pouch, leading to acute or recurrent/chronic pouchitis (R/CP). MicroRNAs (miRNA) are used as accurate diagnostic and predictive biomarkers in many human diseases, including inflammatory bowel diseases. Therefore, we aimed to identify an miRNA-based biomarker to predict the occurrence of R/CP in patients with UC after colectomy and IPAA.
We conducted a retrospective study in 3 tertiary centers in France. We included patients with UC who had undergone IPAA with or without subsequent R/CP. Paraffin-embedded biopsies collected from the terminal ileum during the proctocolectomy procedure were used for microarray analysis of miRNA expression profiles. Deep neural network-based classifiers were used to identify biomarkers predicting R/CP using miRNA expression and relevant biological and clinical factors in a discovery cohort of 29 patients. The classification algorithm was tested in an independent validation cohort of 28 patients.
A combination of 11 miRNA expression profiles and 3 biological/clinical factors predicted the outcome of R/CP with 88% accuracy (area under the curve = 0.94) in the discovery cohort. The performance of the classification algorithm was confirmed in the validation cohort with 88% accuracy (area under the curve = 0.90). Apoptosis, cytoskeletal regulation by Rho GTPase, and fibroblast growth factor signaling were the most dysregulated targets of the 11 selected miRNAs.
We developed and validated a computational miRNA-based algorithm for accurately predicting R/CP in patients with UC after IPAA.
回肠贮袋肛管吻合术(IPAA)是溃疡性结肠炎(UC)全结肠切除术后的标准治疗方法。然而,贮袋常发生炎症,导致急性或复发性/慢性贮袋炎(R/CP)。微小 RNA(miRNA)已被用作许多人类疾病(包括炎症性肠病)的准确诊断和预测生物标志物。因此,我们旨在确定一种基于 miRNA 的生物标志物,以预测接受结肠切除和 IPAA 术后 UC 患者 R/CP 的发生。
我们在法国的 3 个三级中心进行了一项回顾性研究。我们纳入了接受 IPAA 治疗且有或无后续 R/CP 的 UC 患者。在结肠切除术中,从末端回肠采集石蜡包埋的活检标本,用于 miRNA 表达谱的微阵列分析。使用深度神经网络分类器,基于 miRNA 表达和相关生物学及临床因素,在 29 例患者的发现队列中识别预测 R/CP 的生物标志物。该分类算法在 28 例患者的独立验证队列中进行了测试。
11 个 miRNA 表达谱和 3 个生物学/临床因素的组合在发现队列中对 R/CP 的结果进行预测的准确率为 88%(曲线下面积=0.94)。分类算法在验证队列中的性能得到了验证,准确率为 88%(曲线下面积=0.90)。凋亡、Rho GTPase 调节细胞骨架和成纤维细胞生长因子信号通路是 11 个选定 miRNA 最失调的靶标。
我们开发并验证了一种计算 miRNA 为基础的算法,可准确预测接受 IPAA 治疗后的 UC 患者 R/CP 的发生。